Hit to lead services


Drug discovery services from hit-to-lead


Fluofarma provides drug discovery services from hits identification to leads characterization. Thanks to Fluofarma technology, you will be able to use cell-based assays during all your drug discovery process.

Fluofarma offers comprehensive hit-to-lead services:

  • Design of cell-based assays for targeted primary screening
  • Hits comparison & leads selection (potency, efficacy, EC50…)
  • Predictive toxicity testing at large scale
  • Leads’ mechanism of action studies

For more information on our hit to lead services


If you need to have further details on our hit to lead services, do not hesitate to contact us







Hit to lead services

FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to compare and profile your anti-cancer drugs. Read more [+]